New York S06736 requires Medicaid to cover a wearable medical device for treating glioblastoma and other cancers.

New York S06736 amends the social services law to mandate Medicaid coverage for a wearable medical device that uses low-intensity, alternating electric fields to treat glioblastoma and other cancers. The coverage is based on medical and scientific evidence, including FDA approvals, Medicare coverage determinations, and recognized clinical practice guidelines. The act aims to ensure access to innovative cancer treatments for eligible patients.

New York S06736 requires Medicaid to cover a wearable medical device for treating glioblastoma and other cancers.

New York S06736 amends the social services law to mandate Medicaid coverage for a wearable medical device that uses low-intensity, alternating electric fields to treat glioblastoma and other cancers. The coverage is based on medical and scientific evidence, including FDA approvals, Medicare coverage determinations, and recognized clinical practice guidelines. The act aims to ensure access to innovative cancer treatments for eligible patients.